Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
Evotec AG

BRIEF

published on 09/26/2024 at 07:35, 1 month 25 days ago

Evotec and Novo Nordisk Enter Partnership for Next-Generation Cell Therapies

Partnership Cell Therapy Stem Cells Evotec Novo Nordisk
PRESS RELEASE

published on 09/26/2024 at 07:30, 1 month 25 days ago

Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
Evotec and Novo Nordisk partner for next-gen cell therapies. Novo Nordisk funds Evotec for tech development in stem cell-based therapies, aiming for clinical and commercial success

Partnership Evotec Technology Development Novo Nordisk Cell Therapies
BRIEF

published on 09/20/2024 at 15:34, 2 months ago

Evotec SE Opens J.POD® Biologics Facility in Toulouse, France

Sustainability Evotec Toulouse Biologics J.POD®
PRESS RELEASE

published on 09/20/2024 at 15:29, 2 months ago

Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU)
Just - Evotec Biologics opens cutting-edge J.POD biologics facility in Toulouse, France (EU) with scalable manufacturing technology for clinical and commercial supply solutions

Manufacturing Technology Just - Evotec Biologics Toulouse J.POD Biologics Facility
BRIEF

published on 09/03/2024 at 07:35, 2 months 18 days ago

Evotec Announces Change in Management Board

Management Change Evotec Biologics Dr. Matthias Evers Cyber-attack Recovery
PRESS RELEASE

published on 09/03/2024 at 07:30, 2 months 18 days ago

Evotec announces change in Management Board
Evotec SE announces change in Management Board as Chief Business Officer steps down effective October 2024. Distribution of responsibilities among Management Board functions

Evotec SE Management Board Distribution Chief Business Officer Responsibilities
BRIEF

published on 08/14/2024 at 07:05, 3 months 7 days ago

Evotec SE Reports H1 2024 Results: A Transformational Period

Revenue Growth Profitability Transformation Evotec H1 2024 Results
PRESS RELEASE

published on 08/14/2024 at 07:00, 3 months 7 days ago

Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
Evotec SE reports challenging H1 2024 results with priority reset for sustainable growth. New CEO accelerates transformation program focusing on core strengths

Evotec SE Sustainable Growth Transformation Program CEO Change H1 2024 Results
BRIEF

published on 08/13/2024 at 07:35, 3 months 8 days ago

Evotec Reports Significant Progress in Collaboration with Bristol Myers Squibb

Oncology Evotec Bristol Myers Squibb Molecular Glue Degraders CELMoDs
PRESS RELEASE

published on 08/13/2024 at 07:30, 3 months 8 days ago

Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Evotec SE announces strong progress in strategic partnership with Bristol Myers Squibb for molecular glue degraders, triggering payments of US$75m. Joint pipeline expanding in oncology field

Partnership Evotec SE Oncology Bristol Myers Squibb Molecular Glue Degraders

Accesswire

Published on 11/21/2024 at 13:30, 10 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:00, 40 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 40 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 40 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 40 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 25 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 5 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 25 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 33 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 40 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 20 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE